Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.9413
+0.0833 (9.71%)
Oct 9, 2025, 11:25 AM EDT - Market open
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of $72.34 million as of October 9, 2025. Its market cap has increased by 183.79% in one year.
Market Cap
72.34M
Enterprise Value
45.61M
1-Year Change
183.79%
Ranking
Category
Stock Price
$0.94
Market Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has decreased from $226.28M to $72.34M, a decrease of -68.03%. That is a compound annual growth rate of -13.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 57.82M | -16.27% |
| Dec 31, 2024 | 69.05M | -42.03% |
| Dec 29, 2023 | 119.13M | -2.89% |
| Dec 30, 2022 | 122.67M | -65.85% |
| Dec 31, 2021 | 359.22M | -5.17% |
| Dec 31, 2020 | 378.78M | 3.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 2, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 761.49B |
| Johnson & Johnson | 455.10B |
| AbbVie | 408.64B |
| UnitedHealth Group | 337.07B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 232.13B |